Product category:
Contract research
News Release from: Chiltern International
Edited by the Laboratorytalk Editorial
Team on 03 February 2004
New UK director of operations
Chiltern International appoints Ed Richards, formerly VP at PRA, as its UK director of operations
Chiltern International, which claims to be the largest privately held global CRO in the UK, has announced the appointment of Ed Richards as UK director of operations Before joining Chiltern, Richards was the vice president of UK operations for PRA International, building up its UK operation over a five-year period
This article was originally published on Laboratorytalk on 10 Feb 2004 at 8.00am (UK)
Related stories
General manager for Chiltern France
Claude Albrecht will be responsible for ensuring high levels of service to clients, focussing on the development of the French operation
Long term strategy the key to success
In a recent lecture to biomedical students at Kings College London, Faiz Kermani outlined how more and more R and D projects have been given the green light over the last six months
Prior to that he worked in the pharmaceutical industry, initially for the American firm Cyanamid in both the UK and US, where he became director of its European Clinical Research Centre in Richmond, Surrey.
Following that he worked for Fujisawa in Munich, as head of biometrics.
He has a BSc and PhD from Imperial College, London, in chemistry, with specialism in statistical mechanics and thermodynamics.
He continued his research in physical chemistry with post-doctoral fellowships at McMaster University in Canada and Edinburgh University in Scotland.
Established in London in 1982, clinical research organisation Chiltern International provides clinical operations, project management, data management, biostatistics, medical writing, quality assurance and regulatory and medical affairs services to the pharmaceutical, biotechnology and medical device industries.
The company also offers clinical contract personnel services to pharmaceutical and biotechnology clients.
It has ten international offices - three in the United States and seven in Europe.
Commenting on his new role at Chiltern, Richards explained: "I'm very pleased to have joined Chiltern International at this exciting stage of its development.
"With the obvious high calibre of people involved in all parts of the organisation, the ability of the company to make very significant contributions to clinical development on behalf of our clients will continue to grow from an already firm base.".
• Chiltern International: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

